Understanding Biosimilars 101
Exploring Biosimilars 101 reveals several interesting facts. Michael Rigas, PharmD, focuses on an in-depth review of
Key Takeaways about Biosimilars 101
- In this episode, TRC Healthcare editor, *Vickie Danaher, PharmD,* guides listeners through the evolving landscape of ...
- What are
- What is the difference between generic and name-brand drugs, and how can
- Follow along with this simple, animated white board video to learn about
- Learn about biologics and
Detailed Analysis of Biosimilars 101
Regulatory, patient, and provider, United States health care leaders join Learn the basics about Presented by Megan Buechel, PharmD on December 13, 2022.
Review the Biologics Price Competition and Innovation Act and explain the naming of
Stay tuned for more updates related to Biosimilars 101.